Chronic Heart Failure and Coronary Artery Disease: Pharmacological Treatment and Cardiac Rehabilitation

Area of Science:

• Cardiology
• Internal Medicine

Background:

• Coronary artery disease (CAD) is the primary cause of acute and chronic heart failure (HF).
• Effective management necessitates a tailored, multidisciplinary approach for patients with HF and ischemic heart disease.

Purpose of the Study:

• To provide an updated overview of current pharmacological treatments for chronic heart failure (HF) in patients with coronary artery disease (CAD).
• To outline contemporary cardiac rehabilitation strategies for this patient population.
• To propose tailored management plans for clinical practice.

Main Methods:

• Review of recent advancements in pathophysiology, exercise, and pharmacology related to HF and CAD.
• Assessment of key factors including HF symptoms, angina, electrocardiographic features, ventricular function, serological markers, cardiac integrity, and pulmonary function.
• Synthesis of evidence for pharmacological and non-pharmacological interventions.

Main Results:

• Updated pharmacological treatments and cardiac rehabilitation strategies can significantly reduce mortality and hospitalization risks in HF patients with CAD.
• Comprehensive assessment of multiple clinical factors is crucial for effective treatment planning.
• Recent developments enhance understanding of disease mechanisms and therapeutic options.

Conclusions:

• Tailored, multidisciplinary management integrating updated pharmacological therapies and cardiac rehabilitation is essential for patients with chronic heart failure and coronary artery disease.
• Contemporary clinical practice should adopt these evidence-based strategies for improved patient outcomes.
• Personalized treatment plans are critical for this vulnerable patient group.